High-dose chemotherapy in breast cancer: Dutch randomized studies

por Rodenhuis, S, van Tinteren, H, de Vries, EGE
Publicado 2001

Adjuvant treatment in colorectal cancer

por Taal, B G, van Tinteren, H, van t Veer, L
Publicado 2002

Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III

por Taal, B G, Van Tinteren, H, Zoetmulder, F A N
Publicado 2001

A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer.

por Michalides, R., Hageman, P., van Tinteren, H., Houben, L., Wientjens, E., Klompmaker, R., Peterse, J.
Publicado 1996

Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment

por Michalides, R, van Tinteren, H, Balkenende, A, Vermorken, J B, Benraadt, J, Huldij, J, van Diest, P
Publicado 2002

Clinical benefit of systemic therapies for recurrent ovarian cancer—ESMO-MCBS scores

por Broekman, K.E., van Kruchten, M., van Tinteren, H., Sessa, C., Jalving, M., Reyners, A.K.L.
Publicado 2021

Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option

por Meulendijks, D, Dewit, L, Tomasoa, N B, van Tinteren, H, Beijnen, J H, Schellens, J H M, Cats, A
Publicado 2014

Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study

por Baas, P, Belderbos, J S A, Senan, S, Kwa, H B, van Bochove, A, van Tinteren, H, Burgers, J A, van Meerbeeck, J P
Publicado 2006

Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours.

por Dercksen, M. W., Hoekman, K., ten Bokkel Huinink, W. W., Rankin, E. M., Dubbelman, R., van Tinteren, H., Wagstaff, J., Pinedo, H. M.
Publicado 1993

Long-term impact of the 70-gene signature on breast cancer outcome

por Drukker, C. A., van Tinteren, H., Schmidt, M. K., Rutgers, E. J. Th., Bernards, R., van de Vijver, M. J., van’t Veer, L. J.
Publicado 2014

Soluble epidermal growth factor receptor (sEGFR) and carcinoembryonic antigen (CEA) concentration in patients with non-small cell lung cancer: correlation with survival after erlot...

por Kappers, I, Vollebergh, M A, van Tinteren, H, Korse, C M, Nieuwenhuis, L L, Bonfrer, J M G, Klomp, H M, van Zandwijk, N, van den Heuvel, M M
Publicado 2010

The Breast Imaging Reporting and Data System (BI-RADS) in the Dutch breast cancer screening programme: its role as an assessment and stratification tool

por Timmers, J. M. H., van Doorne-Nagtegaal, H. J., Zonderland, H. M., van Tinteren, H., Visser, O., Verbeek, A. L. M., den Heeten, G. J., Broeders, M. J. M.
Publicado 2012

A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study

por Drukker, CA, Bueno-de-Mesquita, JM, Retèl, VP, van Harten, WH, van Tinteren, H, Wesseling, J, Roumen, RMH, Knauer, M, van 't Veer, LJ, Sonke, GS, Rutgers, EJT, van de Vijver, MJ, Linn, SC
Publicado 2013

Treatment and outcome of patients with relapsed clear cell sarcoma of the kidney: a combined SIOP and AIEOP study

por Gooskens, S L, Furtwängler, R, Spreafico, F, van Tinteren, H, de Kraker, J, Vujanic, G M, Leuschner, I, Coulomb-L'Herminé, A, Godzinski, J, Schleiermacher, G, Stoneham, S, Bergeron, C, Pritchard-Jones, K, Graf, N, van den Heuvel-Eibrink, M M
Publicado 2014

Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001

por Hol, J. A., Lopez-Yurda, M. I., Van Tinteren, H., Van Grotel, M., Godzinski, J., Vujanic, G., Oldenburger, F., De Camargo, B., Ramírez-Villar, G. L., Bergeron, C., Pritchard-Jones, K., Graf, N., Van den Heuvel-Eibrink, M. M.
Publicado 2019

Molecular subtypes of breast cancer and amplification of topoisomerase IIα: predictive role in dose intensive adjuvant chemotherapy

por Hannemann, J, Kristel, P, van Tinteren, H, Bontenbal, M, van Hoesel, Q G C M, Smit, W M, Nooij, M A, Voest, E E, van der Wall, E, Hupperets, P, de Vries, E G E, Rodenhuis, S, van de Vijver, M J
Publicado 2006

Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms

por Drukker, C. A., Nijenhuis, M. V., Bueno-de-Mesquita, J. M., Retèl, V. P., van Harten, W. H., van Tinteren, H., Wesseling, J., Schmidt, M. K., van’t Veer, L. J., Sonke, G. S., Rutgers, E. J. T., van de Vijver, M. J., Linn, S. C.
Publicado 2014

An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients

por Vollebergh, M. A., Lips, E. H., Nederlof, P. M., Wessels, L. F. A., Schmidt, M. K., van Beers, E. H., Cornelissen, S., Holtkamp, M., Froklage, F. E., de Vries, E. G. E., Schrama, J. G., Wesseling, J., van de Vijver, M. J., van Tinteren, H., de Bruin, M., Hauptmann, M., Rodenhuis, S., Linn, S. C.
Publicado 2011

Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature

por Opdam, M., van der Noort, V., Kleijn, M., Glas, A., Mandjes, I., Kleiterp, S., Hilbers, F. S., Kruger, D. T., Bins, A. D., de Jong, P. C., Schiphorst, P. P. J. B. M., van Dalen, T., Flameling, B., Rietbroek, R. C., Beeker, A., van den Heiligenberg, S. M., Bakker, S. D., Wymenga, A. N. M., Oving, I. M., Bijlsma, R. M., van Diest, P. J., Vermorken, J. B., van Tinteren, H., Linn, S. C.
Publicado 2022

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study prot...

por Koemans, W. J., van der Kaaij, R. T., Boot, H., Buffart, T., Veenhof, A. A. F. A., Hartemink, K. J., Grootscholten, C., Snaebjornsson, P., Retel, V. P., van Tinteren, H., Vanhoutvin, S., van der Noort, V., Houwink, A., Hahn, C., Huitema, A. D. R., Lahaye, M., Los, M., van den Barselaar, P., Imhof, O., Aalbers, A., van Dam, G. M., van Etten, B., Wijnhoven, B. P. L., Luyer, M. D. P., Boerma, D., van Sandick, J. W.
Publicado 2019